For the Inventor, By the Inventor

Enter assignee name

Bergenbio Asa

USPTO Granted Patents = 13

EPO Patents = 4

Trademarks = 5

Forward Citations = 15

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

David Robert Micklem (8 out of 11 patents)

Linn Nilsson (7 out of 8 patents)

Sergej Kiprijanov (6 out of 14 patents)

4. Lavina Ahmed (6 out of 7 patents)

5. James Bradley Lorens (5 out of 14 patents)

6. Tone Sandal (3 out of 4 patents)

7. Hallvard Haugen (3 out of 3 patents)

8. Stuart Thomas Onions (2 out of 65 patents)

9. John Paul Watts (2 out of 10 patents)

10. Jason John Shiers (2 out of 6 patents)

11. Mohammed Abdul Quddus (2 out of 2 patents)

12. Joseph William Wrigglesworth (2 out of 5 patents)

13. Colin Peter Sambrook-Smith (2 out of 4 patents)

14. Alan Naylor (2 out of 57 patents)

15. Derek John Londesbrough (2 out of 11 patents)

13 patents: Sort by Forward Citations

1. 11732048 - Anti-axl antagonistic antibodies (2023-08-22),

2. 11584796 - Anti-Axl antagonistic antibodies (2023-02-21),

3. 11534440 - Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus (2022-12-27),

4. 11198734 - Anti-Axl antagonistic antibodies (2021-12-14),

5. 11186643 - Anti-Axl antibodies (2021-11-30),

6. 11059893 - Humanized anti-AXL antibodies (2021-07-13),

7. 11035008 - Biomarkers for cancer (2021-06-15),

8. 10766861 - Pharmaceutically active compounds (2020-09-08),

9. 10336702 - Pharmaceutically active compounds (2019-07-02),

10. 10317405 - Methods of detecting Akt3 and administering Ax1 inhibitor (2019-06-11),

11. 9975954 - Anti-Axl antibodies (2018-05-22),

12. 9975953 - Anti-Axl antibodies (2018-05-22),

13. 9783801 - Methods for creating and identifying functional RNA interference elements (2017-10-10),

BerGenBio ASA is a clinical-stage biopharmaceutical company focused on developing innovative therapies for aggressive cancers. They specialize in targeting the AXL signaling pathway, which plays a key role in promoting tumor growth, immune evasion, and treatment resistance. BerGenBio's pipeline includes several novel drug candidates and they are committed to improving patient outcomes through their cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#3 in Bergen

#121 in Norway

#43,690 in the World

Bergenbio Asa

Forward Citations = 15

21 inventors:

David Robert Micklem (8 out of 11 patents)

Linn Nilsson (7 out of 8 patents)

Sergej Kiprijanov (6 out of 14 patents)

4. Lavina Ahmed (6 out of 7 patents)

5. James Bradley Lorens (5 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…